CurveBeam AI Limited (ASX:CVB)

Australia · Delayed Price · Currency is AUD

0.0170

0.00 (0.00%)

At close: Jul 17, 2026

-75.71% (1Y)

Market Cap	8.12M -70.3%
Revenue (ttm)	12.15M +53.7%
Net Income	-16.17M
EPS	-0.04
Shares Out	477.73M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	458,720
Open	0.0170
Previous Close	0.0170
Day's Range	0.0160 - 0.0170
52-Week Range	0.0160 - 0.1750
Beta	2.05
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 30, 2026

About CurveBeam AI

CurveBeam AI Limited engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe, North America, and Australia. The company offers HiRise for bilateral weight bearing CT imaging; LineUP, a bilateral, weight bearing CT imaging of the knees and lower extremities for orthpedic practices; pedCAT Premium and pedCAT for imaging of the foot and ankle; InReach, a point-of-care extremity CT imaging which assess the distal extremities with 3D clarity at a fraction of the dose; and CubeVue Sof... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2009

Employees 50

Stock Exchange Australian Securities Exchange

Ticker Symbol CVB

Full Company Profile

Financial Performance

In fiscal year 2025, CurveBeam AI's revenue was 12.10 million, an increase of 85.33% compared to the previous year's 6.53 million. Losses were -16.84 million, -27.09% less than in 2024.

Financial Statements